Clinicopathological Features and Outcome of Lung Cancer Patients with Hematological Malignancy

[1]  L. Bubendorf,et al.  Lung resection in hematologic patients with pulmonary invasive fungal disease. , 2012, Chest.

[2]  P Das,et al.  Lung malignancies after Hodgkin lymphoma: disease characteristics, detection methods and clinical outcome. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[3]  Hiroshi Nishimoto,et al.  Cancer incidence and incidence rates in Japan in 2008: a study of 25 population-based cancer registries for the Monitoring of Cancer Incidence in Japan (MCIJ) project. , 2012, Japanese journal of clinical oncology.

[4]  Anthony J. Swerdlow,et al.  Second cancer risk after chemotherapy for Hodgkin's lymphoma: a collaborative British cohort study. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  P. Wallace,et al.  Metachronous and synchronous presentation of acute myeloid leukemia and lung cancer. , 2009, Leukemia research.

[6]  B. Johansson,et al.  Smoking as a risk factor for myelodysplastic syndromes and acute myeloid leukemia and its relation to cytogenetic findings: a case-control study. , 2009, Leukemia research.

[7]  A. Howell,et al.  Lung cancer after treatment for Hodgkin's lymphoma: a systematic review. , 2005, The Lancet. Oncology.

[8]  John D Boice,et al.  Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease. , 2002, Journal of the National Cancer Institute.

[9]  D. Parkin,et al.  Global cancer statistics in the year 2000. , 2001, The Lancet. Oncology.

[10]  N. Yamaguchi,et al.  Epidemiological analysis of site relationships of synchronous and metachronous multiple primary cancers in the National Cancer Center, Japan, 1962-1996. , 1999, Japanese journal of clinical oncology.

[11]  A. Hagenbeek,et al.  Roles of radiotherapy and smoking in lung cancer following Hodgkin's disease. , 1995, Journal of the National Cancer Institute.

[12]  W. Ajiki,et al.  Cancer incidence and incidence rates in Japan in 2006: based on data from 15 population-based cancer registries in the monitoring of cancer incidence in Japan (MCIJ) project. , 2012, Japanese journal of clinical oncology.